Gebro Pharma GmbH
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1947-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.gebro.com
Clinical Trials
5
Active:3
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 4:1
Drug Approvals
1
CIMA_AEMPS:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 4
1 (50.0%)Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee
Phase 4
Completed
- Conditions
- Osteoarthritis of the Hip or Knee
- Interventions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Gebro Pharma GmbH
- Target Recruit Count
- 482
- Registration Number
- NCT01066676
- Locations
- 🇦🇹
Rehabzentrum für Erkrankungen des rheumat. Formenkreises, Bad Hofgastein, Salzburg, Austria
🇦🇹Rheuma Zentrum Favoriten, Vienna, Austria
S(+)-Ibuprofen Effects on Asprin Treated Volunteers
Phase 1
Completed
- Conditions
- Drug Interactions
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2012-03-13
- Lead Sponsor
- Gebro Pharma GmbH
- Target Recruit Count
- 72
- Registration Number
- NCT00442585
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria
News
No news found